Baidu
map

2016基于肠促胰素治疗药物临床应用的快速建议指南发布

2016-07-12 MedSci MedSci原创

肠促胰素( incretin) 是一种经食物刺激后由肠道细胞分泌入血、能够刺激胰岛素分泌的激素。 基于肠促胰素的治疗药物(incretin based therapies, IBTs)通过与器官上的特异性受体结合,从而发挥其降糖作用。由于这类药物具有低血糖风险小和改善胰岛细胞功能等多方面的优势,逐渐在临床广泛使用。目前在国内已经上市了2种胰升糖素样肽1受体激动剂( glucagon-like pe

肠促胰素( incretin) 是一种经食物刺激后由肠道细胞分泌入血、能够刺激胰岛素分泌的激素。 基于肠促胰素的治疗药物(incretin based therapies, IBTs)通过与器官上的特异性受体结合,从而发挥其降糖作用。由于这类药物具有低血糖风险小和改善胰岛细胞功能等多方面的优势,逐渐在临床广泛使用。目前在国内已经上市了2种胰升糖素样肽1受体激动剂( glucagon-like peptide-1 receptor agonists, GLP-1RA) :包括艾塞那肽( exenatide) 和利拉鲁肽( liraglutide) ,5种二肽基肽酶郁抑制剂 ( dipeptidyl peptidase-4 inhibitor, DPP-4i) :包括西格列汀( sitagliptin) 、维格列汀( vildagliptin ) 、沙格列汀( saxagliptin ) 、利格列汀(linagliptin)和阿格列汀( alogliptin) ,以及 2 种复方制剂。
 
基于肠促胰素的治疗药物的出现为临床医生提供了更多选择,但它们的有效性、安全性和经济性究竟如何? 基于肠促胰素的治疗药物在特殊人群(如老年患者等)中使用有哪些注意事项? 特别是当这些药物所基于的大量证据都来自于欧美发达国家时,我们该如何评价、选择和应用? 这些问题都有待于采用系统、科学的方法来回答。
 
随着降糖药物的种类不断增加,各学(协)会于2015年陆续更新出版2型糖尿病的相关治疗指南,但未对基于肠促胰素的治疗药物在临床的具体应用进行详细的阐述。2014年1月,中华医学会糖尿病分会制定了《基于胰高血糖素样肽1降糖药的临床应用共识》,对指导临床用药起到了积极的推动作用,然而该共识主要基于专家的意见,未对证据进行全面的检索和评价。因此在全面更新我国上市的 7种基于肠促胰素治疗药物的临床证据的基础上,中华医学会内分泌学分会和中国药学会医院药学专业委员会按照循证指南制定的方法与步骤,组建多学科团队,通过调查临床使用中的实际问题,根据这些问题制定了《基于肠促胰素治疗药物临床应用的快速建议指南》 ,以期为临床医生和临床药师提供更符合临床实践需求的科学和具体的指导。


全文获取

下载地址:指南下载(需要扣积分5分, 梅斯医学APP免积分下载)

会议推荐:
2016天然药物研讨会——探索与发现
http://www.bioon.com/z/2016natural-products/Index.shtml

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1835630, encodeId=e6fb1835630a5, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Sat Feb 04 09:05:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921650, encodeId=a9de192165014, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Wed Sep 07 08:05:00 CST 2016, time=2016-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944912, encodeId=6264194491212, content=<a href='/topic/show?id=88678152506' target=_blank style='color:#2F92EE;'>#肠促胰素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81525, encryptionId=88678152506, topicName=肠促胰素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Sun Dec 25 00:05:00 CST 2016, time=2016-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132020, encodeId=a6b5132020f2, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:15:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=125680, encodeId=e0e4125680e5, content=规范的用药指导对医生成长很有利,对患者病情恢复更有利,学习了,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Tue Sep 13 20:09:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92916, encodeId=06dc92916db, content=挺好的啊,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20751724934, createdName=QQ76174b26, createdTime=Wed Jul 13 09:42:00 CST 2016, time=2016-07-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1835630, encodeId=e6fb1835630a5, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Sat Feb 04 09:05:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921650, encodeId=a9de192165014, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Wed Sep 07 08:05:00 CST 2016, time=2016-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944912, encodeId=6264194491212, content=<a href='/topic/show?id=88678152506' target=_blank style='color:#2F92EE;'>#肠促胰素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81525, encryptionId=88678152506, topicName=肠促胰素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Sun Dec 25 00:05:00 CST 2016, time=2016-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132020, encodeId=a6b5132020f2, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:15:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=125680, encodeId=e0e4125680e5, content=规范的用药指导对医生成长很有利,对患者病情恢复更有利,学习了,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Tue Sep 13 20:09:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92916, encodeId=06dc92916db, content=挺好的啊,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20751724934, createdName=QQ76174b26, createdTime=Wed Jul 13 09:42:00 CST 2016, time=2016-07-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1835630, encodeId=e6fb1835630a5, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Sat Feb 04 09:05:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921650, encodeId=a9de192165014, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Wed Sep 07 08:05:00 CST 2016, time=2016-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944912, encodeId=6264194491212, content=<a href='/topic/show?id=88678152506' target=_blank style='color:#2F92EE;'>#肠促胰素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81525, encryptionId=88678152506, topicName=肠促胰素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Sun Dec 25 00:05:00 CST 2016, time=2016-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132020, encodeId=a6b5132020f2, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:15:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=125680, encodeId=e0e4125680e5, content=规范的用药指导对医生成长很有利,对患者病情恢复更有利,学习了,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Tue Sep 13 20:09:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92916, encodeId=06dc92916db, content=挺好的啊,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20751724934, createdName=QQ76174b26, createdTime=Wed Jul 13 09:42:00 CST 2016, time=2016-07-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1835630, encodeId=e6fb1835630a5, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Sat Feb 04 09:05:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921650, encodeId=a9de192165014, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Wed Sep 07 08:05:00 CST 2016, time=2016-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944912, encodeId=6264194491212, content=<a href='/topic/show?id=88678152506' target=_blank style='color:#2F92EE;'>#肠促胰素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81525, encryptionId=88678152506, topicName=肠促胰素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Sun Dec 25 00:05:00 CST 2016, time=2016-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132020, encodeId=a6b5132020f2, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:15:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=125680, encodeId=e0e4125680e5, content=规范的用药指导对医生成长很有利,对患者病情恢复更有利,学习了,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Tue Sep 13 20:09:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92916, encodeId=06dc92916db, content=挺好的啊,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20751724934, createdName=QQ76174b26, createdTime=Wed Jul 13 09:42:00 CST 2016, time=2016-07-13, status=1, ipAttribution=)]
    2016-09-21 1e10c84am36(暂无匿称)

    文章很好,非常有益

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1835630, encodeId=e6fb1835630a5, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Sat Feb 04 09:05:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921650, encodeId=a9de192165014, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Wed Sep 07 08:05:00 CST 2016, time=2016-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944912, encodeId=6264194491212, content=<a href='/topic/show?id=88678152506' target=_blank style='color:#2F92EE;'>#肠促胰素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81525, encryptionId=88678152506, topicName=肠促胰素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Sun Dec 25 00:05:00 CST 2016, time=2016-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132020, encodeId=a6b5132020f2, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:15:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=125680, encodeId=e0e4125680e5, content=规范的用药指导对医生成长很有利,对患者病情恢复更有利,学习了,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Tue Sep 13 20:09:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92916, encodeId=06dc92916db, content=挺好的啊,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20751724934, createdName=QQ76174b26, createdTime=Wed Jul 13 09:42:00 CST 2016, time=2016-07-13, status=1, ipAttribution=)]
    2016-09-13 舒心和人

    规范的用药指导对医生成长很有利,对患者病情恢复更有利,学习了,感谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1835630, encodeId=e6fb1835630a5, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Sat Feb 04 09:05:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921650, encodeId=a9de192165014, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Wed Sep 07 08:05:00 CST 2016, time=2016-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944912, encodeId=6264194491212, content=<a href='/topic/show?id=88678152506' target=_blank style='color:#2F92EE;'>#肠促胰素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81525, encryptionId=88678152506, topicName=肠促胰素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Sun Dec 25 00:05:00 CST 2016, time=2016-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132020, encodeId=a6b5132020f2, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:15:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=125680, encodeId=e0e4125680e5, content=规范的用药指导对医生成长很有利,对患者病情恢复更有利,学习了,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Tue Sep 13 20:09:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92916, encodeId=06dc92916db, content=挺好的啊,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20751724934, createdName=QQ76174b26, createdTime=Wed Jul 13 09:42:00 CST 2016, time=2016-07-13, status=1, ipAttribution=)]
    2016-07-13 QQ76174b26

    挺好的啊,学习

    0

相关资讯

Med Clin North Am:以肠促胰素为基础的药物治疗

肠促胰素GLP-1和GIP在血糖代谢中起非常重要的作用,目前已肠促胰素为基础的治疗药物有:GLP-1受体激动剂和DPPVI抑制剂。 GLP-1受体激动剂已经表现出两种临床效果:降低血糖和减轻体重。短效的GLP-1受体激动剂,主要是降低餐后血糖,长效的GLP-1受体激动剂主要指降低空腹血糖。 而DPPV抑制剂在安全降糖的情况下,引发低血糖的风险非常低,而且服药方便。 研

BMJ:基于肠促胰素的药物不会增加胰腺癌风险

研究者对2型糖尿病患者进行了一项基于人群的队列研究,比较基于肠促胰素的药物和磺脲类药物,是否会增加胰腺癌风险。该大型国际多中心的研究在加拿大、美国和英国的六个地点进行,共纳入了2007-1-1至2013-6-30的972 384名患者,随访到2014-6-30.在每一个队列中,研究者都进行了嵌套病例对照分析,胰腺癌与对照组按1:20进行匹配(性别、年龄、进入队列日期、治疗糖尿病的持续时间和随访时间

NEJM:肠促胰素不增加糖尿病患者心力衰竭风险

有人担心患者接受降糖药物包括DPP-4抑制剂和GLP-1类似物能增加心脏衰竭风险。目前正在进行的临床试验可能没有足够大的样本来有效地解决这个问题。在本项研究中,研究人员对来自加拿大四省、美国和英国因心力衰竭住院的患者数据进行了分析。通过嵌套病例对照分析,根据性别、年龄、纳入研究时间、糖尿病病程和随访时间为同一队列的每位病人匹配了20名对照人员,并且对接受肠促胰素药物治疗的患者和接受口服降糖药物治疗

Am JPEM:肠促胰素可能会直接影响机体的血糖、脂质代谢及血流动力学

肠促胰素(GLP-1和GIP)是以葡萄糖依赖的方式,促进胰岛素的分泌的。何谓以葡萄糖依赖的方式,即在高糖状态下,肠促胰素会促进更多的胰岛素分泌。大鼠的细胞学研究证明,在肌肉和肝脏组织中,GLP-1可以通过类似于胰岛素的信号途径,上调葡萄糖代谢,这一发现在人体的肌肉组织中也得以证实。已有研究证明,GLP-1可以抑制内源性葡萄糖的产生,改变脂代谢。但是,GLP-1抑制脂代谢的研究,是高胰岛素状态下得出

JCEM:进食氨基酸同样能产生肠促胰素效应

肠促胰素效应,是指同等量的葡萄糖,口服比静脉注射更能促进移动啊素分泌,这与肠道分泌的两种肠促胰岛素,GIP和GLP-1有关。据研究,口服葡萄糖后,70%-80%的胰岛素分泌与肠促胰素效应有关。但是,这种肠促胰素效应不仅仅只存在于碳水化合物,很可能与其他宏观营养素有关。之前,来自瑞典的Ola Lindgren和他的团队,已经证明,这种肠促胰素效应,在进食脂质时同样存在。最近,他们的研究进一步证明,进

Metabolism:肠促胰素抑制胰岛B细胞的凋亡

糖尿病的发病率持续增加,伴随而来的心血管疾病、肾病的病死率也急剧上升。 近些年来,以肠促胰素为基础的新型抗糖尿病药物,越来越被临床所认可。肠促胰素是由肠道内分泌细胞分泌,以葡萄糖依赖的方式促进胰岛素分泌的激素。主要的肠促胰素,有两种GLP-1和GIP,GLP-1是由远端回结肠的L细胞分泌的,GIP是由十二指肠和上段空肠分泌的。在2005年,以GLP-1为基础的药物,GLP-1类似物艾塞那肽,第一个

Baidu
map
Baidu
map
Baidu
map